Peri-Implantitis Treatment Market Size

  • Report ID: 3922
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Peri-Implantitis Treatment Market Size

Peri-Implantitis Treatment Market size was valued at USD 2.16 Billion in 2023 and is likely to exceed USD 5.72 Billion by the end of 2036, registering over 7.8% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of peri-implantitis treatment is evaluated at USD 2.31 Billion. The growth of the market can be attributed to the growing demand for dental implants since these implants are observed to cause peri-implantitis if they get loose. Additionally, the growing prevalence of oral diseases is also estimated to encourage market growth during the forecast period. According to data from the World Health Organization (WHO), nearly 3.5 billion people are affected by oral diseases across the globe. Moreover, almost 10% of the global population is affected with severe periodontal (gum) disease, which may result in tooth loss.

Furthermore, global peri-implantitis treatment market trends such as poor design of dental implants due to a lack of awareness and technology, excessive mechanical stress, and metal corrosion causing peri-implantitis are expected to have an impact on market growth over the forecast period. Poor design of implants placed in the mouth can be uncomfortable and delivers severe wounds at gum linings or the interior of gums. The growth of the market can be attributed to the growing demand for dental implants, along with the adoption of advanced technology in the oral healthcare sector. The prevalence of oral disease is so high that more than 32 million school hours are lost owing to emergency dental care. Therefore, all these factors are anticipated to boost the growth of the market over the forecast period.


Peri-Implantitis-Treatment-Market-scope
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3922
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of peri-implantitis treatment is evaluated at USD 2.31 Billion.

The peri-implantitis treatment market size was valued at USD 2.16 Billion in 2023 and is likely to exceed USD 5.72 Billion by the end of 2036, registering over 7.8% CAGR during the forecast period i.e., between 2024-2036. Growing consumption of cigarettes and increasing awareness of oral care are the major factors driving the market growth.

Asia Pacific is expected to dominate majority industry share by 2036, attributed to increasing prevalence of oral diseases, along with rising awareness regarding oral health.

Aetna Inc., Pfizer Inc., Cadila Pharmaceuticals Limited, R N Laboratories Pvt Ltd, Neoss Limited, Basic Pharma Lifesciences Pvt Ltd, Dawood and Tanner, Prachi Pharmaceuticals Private Limited, Geistlich Pharma AG., Healthy Life Pharma Private Limited.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample